Target intelligence / Profile preview

Folate metabolism support

Molecular classification
Other
01

Overview

Folate metabolism support" is not the name of a specific molecular target but rather refers to the complex network of enzymes, transporters, and biochemical pathways responsible for the utilization, transport, and intracellular processing of folate (vitamin B9) and its derivatives. Folate metabolism involves multiple steps, including the reduction of folic acid to tetrahydrofolate by dihydrofolate reductase; the transfer and cycling of one-carbon units by enzymes and cofactors like serine hydroxymethyltransferase and methylenetetrahydrofolate reductase (MTHFR); and the action of folate transporters such as SLC46A1 (proton-coupled folate transporter), folate receptor alpha (FRα), and the reduced folate carrier (RFC)[1][2][3][5]. Disruptions in folate metabolism can lead to wide-ranging effects, including impaired DNA synthesis and methylation, elevated homocysteine, developmental disorders, and increased risk for certain cancers and cardiovascular disease[2][5][1]. Numerous drugs (notably antifolates) target enzymes in these pathways, especially as chemotherapeutics or antimicrobials. However, "folate metabolism support" as stated is not a singular canonical molecular target and thus is considered an incorrect or non-specific entry.

Other names
Folate metabolismFolic acid metabolismFolate cycleOne-carbon metabolism
02

Mechanism of action

Enzyme inhibition (e.g., dihydrofolate reductase inhibitors block conversion of folic acid to tetrahydrofolate); Competitive inhibition of biosynthetic enzymes

03

Biological functions

DNA synthesis and repairAmino acid metabolism (methionine, cysteine, serine, glycine, histidine)Methylation reactions (including epigenetic gene regulation)Cell divisionHomocysteine remethylation
04

Disease associations

Cancer (due to aberrant methylation and DNA synthesis disruptions)Cardiovascular disease (via elevated homocysteine)Neural tube defects (developmental disorders caused by deficiency)Cognitive impairment, neurodevelopmental disordersHereditary folate malabsorption (rare, genetic deficiencies in transporters)
05

Safety considerations

Drug-induced folate deficiency (notably with methotrexate, valproic acid, sulfonamides)Risk of neural tube defects in pregnancy with low folatePotential for masking B12 deficiency with excessive supplementation
06

Interacting drugs

Methotrexate (dihydrofolate reductase inhibitor)

4 more in the full profile.

07

Biomarkers

Homocysteine levels (for folate status)Methylation status (epigenetic markers)Folate and vitamin B12 blood levels

Beyond the preview

Go deeper on Folate metabolism support.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folate metabolism support.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call